|
|
|
Abu-Amer Lab - Publications
|
-
Abu-Amer, Y. and Bar-Shavit, Z. Modulation of vitamin D increased H2O2 production and MAC-2 expression in bone marrow-derived macrophages by estrogen. Calcif. Tissue Int. 55:29-32, 1994. PMID: 7922786
-
Abu-Amer, Y. and Bar-Shavit, Z. Regulation of TNF-a release from bone marrow-derived macrophages by vitamin D. J. Cell. Biochem. 55:435-444, 1994. PMID: 7962175
-
Teitelbaum, S.L., Abu-Amer, Y., and Ross, F. P. Molecular mechanisms of bone resorption. J. Cell. Biochem. 59:1-10, 1995. PMID: 8530528
-
Matayoshi, A., Brown, C., Di Persio, J., Haug, J., Abu-Amer, Y., Liapis, H., Kuestner, R., and Pacifici, R. Human blood-mobilized hematopoietic precursors differentiate into osteoclasts in the absence of stromal cells. Proc. Natl. Acad. Sci. 93(20):10785-10790, 1996. PMID: 8855258
-
Abu-Amer, Y., Ross, F.P., Schlesinger, P., Tondravi, M.M., and Teitelbaum, S.L. Substrate recognition by osteoclast precursors induces c-src/microtubule association. J. Cell Biol. 137(1): 247-258, 1997. PMID: 9105052
-
Abu-Amer, Y., Ross, F.P., Edwards, J., Teitelbaum,S.L. Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its p55 receptor. J.Clin.Inves. 100(6):1557-1565, 1997. PMID: 9294124
-
Abu-Amer, Y., and MM. Tondravi. NF-kB and bone: The breaking point. Nature Medicine 11(3),pp 1189-1190, 1997. PMID: 9359684
-
Chappel J., F. P. Ross, Y. Abu-Amer, A. Shaw and S. L. Teitelbaum. 1,25-dihydroxyvitamin D3 regulates pp60c-src activity and expression of a pp60c-src activating phosphatase. J. Cell. Biochem. 67(4):432-438, 1997. PMID: 9383703
-
Abu-Amer, Y., Ross, F.P., McHugh, K., Livolsi A., Peyron J-F., and Teitelbaum, S.L. TNF activation of NF-kB in marrow macrophages is mediated by c-src tyrosine phosphorylation of IkB. J. Biol. Chem. 273(45): 29417-29423, 1998. PMID: 9792645
-
Abu-Amer, Y., Teitelbaum, S.L., and Ross, F.P. Expression and regulation of rab3 proteins in osteoclasts and their precursors. JBMR 14 (11), 1855-1860, 1999. PMID: 10571685
-
Merkel, K.D., Erdmann, J.M., McHugh, K.P., Abu-Amer, Y., Ross, F.P., and Teitelbaum,S.L. Tumor necrosis factor alpha mediates implant osteolysis via its p55 receptor. Am. J. Pathol. 154, 203-210, 1999. PMID: 9916934
-
Adams, A.E., Stueckle, S., Abu-Amer, Y., Ross, F.P., Teitelbaum, S.L., and Suva, L.J. 1,25(OH)2D3 and dexamethasone induce cyclooxygenase-1 but not cyclooxygenase-2 expression by osteoclastogenic stromal cells. J. Cell. Biochem. 74:587-595, 1999. PMID: 10440928
-
Huang Z., Ritter C., Brown A., Finch J., Abu-Amer Y. and E. Slatopolsky. Cloning and Localization of Rab3 Isoforms in Bovine, Rat, and Human Parathyroid Glands. Biochem. Biophys. Res. Comm. 255, 645-651, 1999. PMID: 10049764
-
Mbalaviele G., Abu-Amer Y., Meng A., Jaiswal R., Beck S., Pittenger M., Theide M. and D Marshak. Activation of PPAR-gamma Pathway Inhibits Osteoclast Differentiation. . J. Biol. Chem. 275(19),14388-14393,2000. PMID: 10799521
-
Inoue M., FP. Ross, J. Erdmann, Y. Abu-Amer, and SL. Teitelbaum. TNF regulates avb5 integrin expression by osteoclast precursors in vitro and in vivo. Endocrinology 141(1):284-90,2000. PMID: 10614649
-
Abu-Amer, Y., J. Erdmann, Alexopoulou L., Kollias, G., S.L. Teitelbaum. Tumor Necrosis Factor Receptors Type 1 and 2 Differentially Regulate Osteoclastogenesis. J. Biol. Chem. 275(35):27307-27310,2000. PMID: 10874036
-
Zhang Y-H., Huelsmann A., Tondravi M., Mukhrejee A. and Y. Abu-Amer. Tumor necrosis factor-alpha stimulates RANKL-induced osteoclast recruitment via coupling TNF receptor-1 and RANK signaling pathways. J Biol. Chem. 276(1):563-568,2001. PMID: 11032840
-
Abu-Amer, Y., Interleukin-4 abrogates osteoclastogenesis by mechanisms involving STAT6 inhibition of NF-kB transactivation. J.Clin Invest. 107:1375-1385, 2001. PMID: 11390419
-
Abu-Amer, Y., Dowdy SF., Zhang Y-H., Ross FP., Clohisy JC., SL. Teitelbaum. TAT fusion proteins containing tyrosine-42-deleted IkBa arrest osteoclastogenesis. J Biol. Chem. 276:30499-30503, 2001. PMID: 11408488
-
Clohisy JC., Teitelbaum SL., Chen S., Erdmann J. and Y. Abu-Amer. Tumor necrosis factor-alpha mediates polymethylmethacrylate particle-induced NF-kB activation in osteoclast precursor cells. J. Orthop. Res. 20:174-181, 2002. PMID: 11918294
-
Gupta A, Lee BS, Khadeer MA, Tang Z, Chellaiah M, Abu-Amer Y, Goldknopf J, Hruska KA.. Leupaxin is a linker protein in the clear zone of the osteoclast. J. Bone Min. Res. 18(4):669-85, 2003. PMID: 12675328
-
Clohisy JC., Fraizer E., Hirayama T., and Y. Abu-Amer. RANKL is an essential cytokine mediator of polymethylmethacrylate particle-induced osteoclastogenesis. J. Ortho. Res. 21(2):202-212, 2003. PMID: 12568950
-
Lam J., Abu-Amer, Y., Nelson CA., Fermont D., Ross FP., Teitelbaum SL. Tumor necrosis superfamily cytokines and pathogenesis of inflammatory osteolysis. Annals of Rheumatic Diseases. 61:82-83, 2002. PMID: 12379631
-
Abu-Amer Y: Mechanisms of Inflammatory Mediators in Bone Loss Diseases, in Rosier RN, Evans CH (eds): Molecular Biology in Orthopaedics, Rosemont, IL, American Academy of Orthopaedic Surgeons, 2003, pp 229-239.
-
Khan, E. and Y. Abu-Amer. Activation of PPAR-gamma inhibits differentiation of pre-osteoblasts. J. Lab. Clin. Med. 142:29-34, 2003. PMID: 12878983
-
Abbas S. and Y. Abu-Amer,. Dominant-negative IkB facilitates apoptosis of osteoclasts by tumor necrosis factor. J. Biol. Chem. 278: 20077 – 20082, 2003. PMID: 12637573
-
Abbas S., Zhang Y-H., Clohisy JC., and Y. Abu-Amer. Tumor necrosis factor-alpha inhibits pre-osteoblast differentiation through its type-1 receptor. Cytokine 22:33-41, 2003. PMID: 12946103
-
Abbas S., Clohisy JC., Y. Abu-Amer. Mitogen-activated protein kinases mediate PMMA-induction of osteoclasts. J. Ortho. Res. 21:1041-1048, 2003. PMID: 14554217
-
Clohisy JC., Biondo C., Roy B., Willis D., Teitelbaum SL., Y. Abu-Amer. Direct inhibition of NF-kB blocks bone erosion associated with inflammatory arthritis. J. Immunol. 171:5547-5553, 2003. PMID: 14607962
-
Abu-Amer, Y. and JC Clohisy. Biologic response to orthopedic implants, in Einhorn T., O’Keefe R., and Buckwalter J (eds): Orthopedic Basic Science, ed 3. American Academy of Orthopaedic Surgeons, 2007, pp 365-377.
-
Clohisy JC., Hirayama T., Frazier E., Han S., Y Abu-Amer. NF-kB signaling blockade abolishes implant particle-induced osteoclastogenesis. J. Ortho. Res., 22(1):13-20, 2004. PMID: 14656654
-
Abu-Amer, Y., Abbas, S., Hirayama, T. TNFr1 regulates RANKL expression by stromal cells and modulates osteoclastogenesis. J. Cell. Biochem. 93:980-989, 2004. PMID: 15389885
-
Dai S., Hirayama, T., Abbas, S. and Y. Abu-Amer. The IKK inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis. J. Biol. Chem.; 279: 37219 – 37222, 2004 PMID: 15252035
-
Kitaura H., Sands M., Aya K., Zhou P., Hirayama T., Utugennant B., Takeshita S., Silva M., Abu-Amer, Y., Ross FP., SL. Teitelbaum. Marrow stromal cells and osteoclast precursors differentially contribute to TNF-alpha-induced osteoclastogenesis in vivo. J. Immunol. 173: 4838 – 4846, 2004. PMID: 15470024
-
Silva MJ., Brodt MD., Ko M., and Y. Abu-Amer. Impaired Marrow Osteogenesis is Associated with Reduced Endocortical Bone Formation But Does Not Impair Periosteal Bone Formation in Long Bones of SAMP6 Mice. J. Bone Min. Res. 20:419-427, 2005. PMID: 15746986
-
Abu-Amer, Y. Advances in Osteoclast Differentiation and Function. Curr Drug Targets Immune Endocr Metabol Disord:5:347-55; 2005. PMID: 16178795
-
Hirayama, T., Dai S., Abbas, S., Yamanaka, Y., and Y. Abu-Amer. Constitutively active STAT6 inhibits osteoclastogenesis and inflammatory bone destruction through blockade of JNK activation. Arth. Rheum.:52:2719-2729; 2005. PMID: 16142755
-
Mbalaviele G, Anderson GD, Jones AL, De Ciechi P, Settle SL, Mnich sJ, Thiede MA, Abu-Amer Y, Portanova J, and Monahan JB. Inhibition of p38 mapk prevents inflammatory bone destruction. J Pharmacol Exp Ther 2006; 317:1044-53. PMID: 16501068
-
Yamanaka, Y; Abu-Amer, Y; Faccio, R; Clohisy, JC. The map kinase c-jun n-terminal kinase mediates PMMA-induction of osteoclasts. J Orthop Res 2006; 24:1349-57. PMID: 16732613
-
Clohisy JC, Yamanaka Y, Faccio R, and Y. Abu-Amer. Inhibition of IKK activation, through sequestering NEMO, blocks PMMA-induced osteoclastogenesis and calvarial inflammatory osteolysis. J Orthop Res. 2006 Jul;24(7):1358-65. PMID: 16705717
-
Abu-Amer Y and R. Faccio. Therapeutic approaches in bone pathogenesis: targeting the IKK/NF-kB axis. Future Rheumatol. Vol 1,133-146, 2006
-
Dufort FJ, Bleiman BF, Gumina MR, Blair D, Wagner DJ, Roberts MF, Abu-Amer Y, and Chiles TC.
-
Cutting Edge: IL-4-Mediated Protection of Primary B Lymphocytes from Apoptosis via Stat6-Dependent Regulation of Glycolytic Metabolism. J. Immunol., 2007; 179: 4953 - 4957.
-
Kiesel, J., Miller, C, Abu-Amer, Y., and R. Aurora. Systems level analysis of osteoclastogenesis reveals intrinsic and extrinsic regulatory interactions. Developmental Dynamics. 236:2181-97, 2007.
-
Abu-Amer, Y., Darwech I., and JC. Clohisy. Aseptic Loosening of Total Joint Replacements: mechanisms underlying osteolysis and potential therapies. Arthritis Research & Therapy Vol. 9 (Suppl 1), S6, 2007.
-
Abu-Amer, Yousef; Darwech, Isra and Otero, Jesse (September 2007) Osteoporosis and Osteopetrosis. In: ENCYCLOPEDIA OF LIFE SCIENCES. John Wiley & Sons, Ltd: Chichester http://www.els.net/ [DOI: 10.1002/9780470015902.a0006017]
-
Abu-Amer, Yousef; Darwech, Isra and Otero, Jesse. Role of the NF-kB axis in immune modulation of osteoclasts and bone loss. Autoimmunity 8:1-8, 2007. [DOI: 10.1080/08916930701694543]
- Yamanaka, Y., Abu-Amer, W., Foglia, D., Otero, JE., Clohisy, JC., and Y. Abu-Amer. NFAT2 Is An Essential Mediator Of Orthopedic Particle-Induced Osteoclastogenesis. JOR, in press 2008
|

Yousef Abu-Amer, Ph.D
Associate Professor
Department of Orthopaedics
Washington University
abuamery@wustl.edu
Yalem Building 822
Phone: (314) 362-8597
|